**Core Concept**
Tigecycline is a glycylcycline antibiotic that works by inhibiting protein synthesis in bacteria. It is a broad-spectrum antibiotic that has been used to treat various infections, including those caused by multi-drug resistant organisms.

**Why the Correct Answer is Right**
Tigecycline binds to the 30S subunit of the bacterial ribosome, specifically to the 5' region of the rRNA, and prevents the attachment of aminoacyl-tRNA to the ribosome, thereby inhibiting protein synthesis. This mechanism of action is distinct from other tetracycline antibiotics, which bind to the 30S subunit but at a different site.

**Why Each Wrong Option is Incorrect**
**Option A:** Tigecycline is not a derivative of minocycline. Tigecycline is actually a derivative of tetracycline.
**Option B:** Tigecycline is actually used for the treatment of complicated intra-abdominal infections, skin and skin structure infections, and community-acquired bacterial pneumonia.
**Option C:** Tigecycline is not a beta-lactam antibiotic. It is a glycylcycline antibiotic, which is a subclass of tetracycline antibiotics.

**Clinical Pearl / High-Yield Fact**
Tigecycline is unique among tetracycline antibiotics because it is resistant to efflux pumps, which makes it effective against multi-drug resistant bacteria. However, it is not effective against MRSA due to its poor penetration into the cell.

**Correct Answer:** B.